This is an old revision of the document!
Symvivo
Symvivo Corporation (or simply Symvivo) is a Canadian biotechnology company based in Burnaby, British Columbia.
COVID-19
Symvivo is developing an oral COVID-19 vaccine called bacTRL-Spike.1)
1)
Symvivo receives funding for COVID-19 vaccine program. (2021, July 19). Symvivo Corporation. https://web.archive.org/web/20220417182902/https://www.symvivo.com/media-2/symvivo-corporation-receives-funding-for-covid-19-vaccine-program